Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Cipla
Healthtrust
Mallinckrodt
Johnson and Johnson
Chubb
Fish and Richardson
Argus Health
McKinsey

Generated: May 26, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021041

« Back to Dashboard

NDA 021041 describes DEPOCYT, which is a drug marketed by Pacira Pharms Inc and is included in one NDA. It is available from one supplier. Additional details are available on the DEPOCYT profile page.

The generic ingredient in DEPOCYT is cytarabine. There are fifteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the cytarabine profile page.
Summary for 021041
Tradename:DEPOCYT
Applicant:Pacira Pharms Inc
Ingredient:cytarabine
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 021041
Medical Subject Heading (MeSH) Categories for 021041
Suppliers and Packaging for NDA: 021041
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DEPOCYT cytarabine INJECTABLE, LIPOSOMAL;INJECTION 021041 NDA Sigma-Tau Pharmaceuticals, Inc. 57665-331 N 57665-331-01

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE, LIPOSOMAL;INJECTIONStrength10MG/ML
Approval Date:Apr 1, 1999TE:RLD:Yes

Expired US Patents for NDA 021041

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pacira Pharms Inc DEPOCYT cytarabine INJECTABLE, LIPOSOMAL;INJECTION 021041-001 Apr 1, 1999 ➤ Sign Up ➤ Sign Up
Pacira Pharms Inc DEPOCYT cytarabine INJECTABLE, LIPOSOMAL;INJECTION 021041-001 Apr 1, 1999 ➤ Sign Up ➤ Sign Up
Pacira Pharms Inc DEPOCYT cytarabine INJECTABLE, LIPOSOMAL;INJECTION 021041-001 Apr 1, 1999 ➤ Sign Up ➤ Sign Up
Pacira Pharms Inc DEPOCYT cytarabine INJECTABLE, LIPOSOMAL;INJECTION 021041-001 Apr 1, 1999 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Teva
US Department of Justice
AstraZeneca
Healthtrust
QuintilesIMS
Federal Trade Commission
Baxter
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.